Pulmonary TB Clinical Trial
Official title:
Comparative Study Between the Classical Strategy and a Faster, Daily Collection for the Diagnosis of Contagious Pulmonary Tuberculosis
Verified date | April 2017 |
Source | Hopital Lariboisière |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Tuberculosis (TB) is a major cause of death among the "communicable" diseases in the world. Pulmonary TB, the main localization, leads to the dissemination of cases. An earlier diagnosis of contagious pulmonary TB is a cornerstone to stop the air transmission. The aim of the study will be to compare two strategies, in patients with a chest-X-ray in favour of contagious pulmonary TB: the classical strategy of sputa collection during three consecutive early mornings, versus the studied strategy of sputa collection at hour h, hour h+1, hour h+2 during the first early morning.
Status | Completed |
Enrollment | 34 |
Est. completion date | April 2017 |
Est. primary completion date | April 2017 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - All adult patients suspected of pulmonary TB (symptoms: lost weight, hemoptysis, chronic cough or fever, or a Chest-X-Ray (CXR) evocative of pulmonary TB) Exclusion Criteria: - Patients who refused or were unable to give written consent |
Country | Name | City | State |
---|---|---|---|
France | Hôpital Lariboisière | Paris | Ile-de-France |
Lead Sponsor | Collaborator |
---|---|
Hopital Lariboisière |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Comparison between the sensitivities of the two strategies for detection of Acid fast bacilli (AFB) on direct stain | Ziehl Neelsen | one year |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00933790 -
Comparing Daily vs Intermittent Regimen of ATT in HIV With Pulmonary Tuberculosis
|
Phase 3 | |
Completed |
NCT04645836 -
Impact of a Pharmacist-led Patient-centred Care Intervention Along With Text-Message Reminders, on the Management of Newly Diagnosed Tubercular Patients: a Protocol for a Randomized Controlled Trial'.
|
N/A | |
Recruiting |
NCT06058299 -
Phase 2 Trial Assessing TBAJ876 or Bedaquiline, With Pretomanid and Linezolid in Adults With Drug-sensitive Pulmonary Tuberculosis
|
Phase 2 | |
Completed |
NCT03722472 -
Phase 1 Clinical Trial of Single-Vial ID93 + GLA-SE in Healthy Adults
|
Phase 1 | |
Completed |
NCT03678688 -
A Phase 1/2 Trial of Multiple Oral Doses of OPC-167832 for Uncomplicated Pulmonary Tuberculosis
|
Phase 1/Phase 2 | |
Completed |
NCT00212550 -
Evaluation of the Practice of Three Morning Sputa on Separate Days for Diagnosis of Mtb
|
N/A | |
Recruiting |
NCT03025516 -
Performance Evaluation of TB Breath- and Cough-testing Platforms
|
N/A | |
Recruiting |
NCT05426720 -
Risk Factors and Biomarkers for Post-tuberculosis Lung Damage
|
||
Recruiting |
NCT04264221 -
Promoting Overall Care and Management Related to Tuberculosis Infection Through Pharmaceutical Care and Text Messaging
|
N/A | |
Active, not recruiting |
NCT05221502 -
Safety and Efficacy Evaluation of 4-month Regimen of OPC-167832, Delamanid and Bedaquiline in Participants With Drug-Susceptible Pulmonary TB
|
Phase 2 |